Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

NPM-ALK Oncoprotein Suppresses Anti-Tumor Immune Responses Partially through Cgas-Sting Pathway in ALK+ Anaplastic Large Cell Lymphoma

Ioanna Xagoraris, Ying Yang, Dora Trogrlic, Alma Mansson, Christina Plastira, Vasiliki Leventaki, Hong Qian, Andreas Lundqvist, George Z. Rassidakis

Blood (2024) 144 (Supplement 1): 2999.

https://doi.org/10.1182/blood-2024-205772

Published: 2024

Journal Articles

Autologous B Cell Maturation Antigen (BCMA) and CD19 Dual Targeting Fastcar-T Cells (GC012F/AZD0120) As First-Line Therapy for Elderly Patients with Newly Diagnosed Multiple Myeloma Patients

Juan Du, Wanting Qiang, Jing Lu, Yanchun Jia, Haiyan He, Jin Liu, Pei Guo, Ying Yang, Zhongyuan Feng, Lina Jin, Xiaoqiang Fan, Nina Shah, Qi Zhang, Jia Liu, Lihong Weng, Lianjun Shen, Wei Cao

Blood (2024) 144 (Supplement 1): 2072.

https://doi.org/10.1182/blood-2024-204774

Published: 2024

Journal Articles

Updated Results of a Phase I Open-Label Single-Arm Study of Dual Targeting BCMA and CD19 Fastcar-T Cells (GC012F) As First-Line Therapy for Transplant-Eligible Newly Diagnosed High-Risk Multiple Myeloma

Juan Du, Wanting Qiang, Jing Lu, Yanchun Jia, Haiyan He, Jin Liu, Pei Guo, Ying Yang, Zhongyuan Feng, Lina Jin, Xiaoqiang Fan, Jia Liu, Qi Zhang, Lianjun Shen, Lihong Weng, Wenling Li, Wei Cao

Blood (2023) 142 (Supplement 1): 1022.

https://doi.org/10.1182/blood-2023-174841

Published: 2023

Journal Articles

Identification of LPAR1/LPAR5 As Novel GPCR Partners of GPRC5D for the Efficient CAR-T Therapy of Multiple Myeloma

Xinyi Zhou, Ying Yang, Xiaoli Hu, Tiancheng Luo, Shangrun Liu, Chao Zhang, Juan Du

Blood (2023) 142 (Supplement 1): 4679.

https://doi.org/10.1182/blood-2023-186150

Published: 2023

Journal Articles

C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse

Li-Xue Yang, Cheng-Tao Zhang, Meng-Ying Yang, Xue-Hong Zhang, Hong-Chen Liu, Chen-Hui Luo, Yue Jiang, Zhang-Man Wang, Zhong-Yin Yang, Zhao-Peng Shi, Yi-Ci Yang, Ruo-Qu Wei, Li Zhou, Jun Mi, Ai-Wu Zhou, Zhi-Rong Yao, Li Xia, Jin-Song Yan, Ying Lu

Blood (2023) 141 (7): 766–786.

https://doi.org/10.1182/blood.2022017046

Published: 2023

Includes: Supplemental data

Journal Articles

Ixazomib, Lenalidomide, and Dexamethasone (IRd) Versus Ixazomib, Pegylated Liposomal Adriamycin, and Dexamethasone(IDd) in Elderly Frail Newly Diagnosed Multiple Myeloma with GA Score ≥2: A Prospective Multicenter Study

Li Bao, Min-qiu Lu, Peng Liu, Yu-Tong Wang, Junling Zhuang, Mei Zhang, Zhongjun Xia, Zhenling Li, Ying Yang, Zhenyu Yan, Hongmei Jing, Wenming Chen, Hebing Zhou, Rong Fu, Yuping Gong, Wenrong Huang, Yongqing Zhang

Blood (2022) 140 (Supplement 1): 12564–12565.

https://doi.org/10.1182/blood-2022-168068

Published: 2022

Journal Articles

Gene Mutation and MRD-Directed Risk Stratification Treatment Improves Long Term Survival of the Patients with AML1-ETO-Positive AML

Dan Xu, Ying Yang, Zhao Yin, Sanfang Tu, Danian Nie, Qixin Sun, Zhengqian Huang, Yu Zhang, Guopan Yu

Blood (2022) 140 (Supplement 1): 9097.

https://doi.org/10.1182/blood-2022-159589

Published: 2022

Journal Articles

Phase I Open-Label Single-Arm Study of BCMA/CD19 Dual-Targeting FasTCAR-T Cells (GC012F) As First-Line Therapy for Transplant-Eligible Newly Diagnosed High-Risk Multiple Myeloma

Juan Du, Weijun Fu, Jing Lu, Wanting Qiang, Haiyan He, Jin Liu, Ying Yang, Zhongyuan Feng, Lina Jin, Xiaoqiang Fan, Jia Liu, Qi Zhang, Lianjun Shen, Lihong Weng, Wei Cao

Blood (2022) 140 (Supplement 1): 889–890.

https://doi.org/10.1182/blood-2022-162295

Published: 2022

Journal Articles

IDH1 mutation contributes to myeloid dysplasia in mice by disturbing heme biosynthesis and erythropoiesis

Blood (2021) 137 (7): 945–958.

https://doi.org/10.1182/blood.2020007075

Published: 2021

Includes: Supplemental data

Journal Articles

Lymphatic endothelial progenitors bud from the cardinal vein and intersomitic vessels in mammalian embryos

Ying Yang, José Manuel García-Verdugo, Mario Soriano-Navarro, R. Sathish Srinivasan, Joshua P. Scallan, Manvendra K. Singh, Jonathan A. Epstein, Guillermo Oliver

Blood (2012) 120 (11): 2340–2348.

https://doi.org/10.1182/blood-2012-05-428607

Published: 2012

Includes: Multimedia, Supplemental data

Journal Articles

Evaluation of Chinese People Quality of Life Who Suffer From Hematologic Diseases

Rong Hu, Ying Yang, Bin Wu, Ke Zhu, Miao Miao, Aijun Liao, Wei Yang, Zhuogang Liu

Blood (2011) 118 (21): 4776.

https://doi.org/10.1182/blood.V118.21.4776.4776

Published: 2011

Journal Articles

Pediatric mastocytosis–associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations

Ying Yang, Sébastien Létard, Laurence Borge, Amandine Chaix, Katia Hanssens, Sophie Lopez, Marina Vita, Pascal Finetti, Daniel Birnbaum, François Bertucci, Sophie Gomez, Paulo de Sepulveda, Patrice Dubreuil

Blood (2010) 116 (7): 1114–1123.

https://doi.org/10.1182/blood-2009-06-226027

Published: 2010

Includes: Supplemental data

Journal Articles

Hsp90 regulates Ulk1-mediated autophagic clearance of mitochondria

Mondira Kundu, MD, PhD, Chia-Ying Yang, PhD, Kelly McCastlain, Junmin Wu, Ji Zhang, PhD, Tullia Lindsten, MD, PhD, Paul Ney, MD, Craig B. Thompson

Blood (2008) 112 (11): 3458.

https://doi.org/10.1182/blood.V112.11.3458.3458

Published: 2008

Journal Articles

Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation

Mondira Kundu, Tullia Lindsten, Chia-Ying Yang, Junmin Wu, Fangping Zhao, Ji Zhang, Mary A. Selak, Paul A. Ney, Craig B. Thompson

Blood (2008) 112 (4): 1493–1502.

https://doi.org/10.1182/blood-2008-02-137398

Published: 2008

Journal Articles

Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells

Blood (2006) 108 (3): 1065–1072.

https://doi.org/10.1182/blood-2005-06-2433

Published: 2006

Journal Articles

Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma

Apostolia M. Tsimberidou, Peter McLaughlin, Anas Younes, Maria A. Rodriguez, Fredrick B. Hagemeister, Andreas Sarris, Jorge Romaguera, Mark Hess, Terry L. Smith, Ying Yang, Ana Ayala, Alejandro Preti, Ming-Sheng Lee, Fernando Cabanillas

Blood (2002) 100 (13): 4351–4357.

https://doi.org/10.1182/blood-2001-12-0269

Published: 2002

NARROW

NPM-ALK Oncoprotein Suppresses Anti-Tumor Immune Responses Partially through Cgas-Sting Pathway in ALK+ Anaplastic Large Cell Lymphoma

Autologous B Cell Maturation Antigen (BCMA) and CD19 Dual Targeting Fastcar-T Cells (GC012F/AZD0120) As First-Line Therapy for Elderly Patients with Newly Diagnosed Multiple Myeloma Patients

Updated Results of a Phase I Open-Label Single-Arm Study of Dual Targeting BCMA and CD19 Fastcar-T Cells (GC012F) As First-Line Therapy for Transplant-Eligible Newly Diagnosed High-Risk Multiple Myeloma

Identification of LPAR1/LPAR5 As Novel GPCR Partners of GPRC5D for the Efficient CAR-T Therapy of Multiple Myeloma

C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse

Ixazomib, Lenalidomide, and Dexamethasone (IRd) Versus Ixazomib, Pegylated Liposomal Adriamycin, and Dexamethasone(IDd) in Elderly Frail Newly Diagnosed Multiple Myeloma with GA Score ≥2: A Prospective Multicenter Study

Gene Mutation and MRD-Directed Risk Stratification Treatment Improves Long Term Survival of the Patients with AML1-ETO-Positive AML

Phase I Open-Label Single-Arm Study of BCMA/CD19 Dual-Targeting FasTCAR-T Cells (GC012F) As First-Line Therapy for Transplant-Eligible Newly Diagnosed High-Risk Multiple Myeloma

IDH1 mutation contributes to myeloid dysplasia in mice by disturbing heme biosynthesis and erythropoiesis

Lymphatic endothelial progenitors bud from the cardinal vein and intersomitic vessels in mammalian embryos

Evaluation of Chinese People Quality of Life Who Suffer From Hematologic Diseases

Pediatric mastocytosis–associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations

Hsp90 regulates Ulk1-mediated autophagic clearance of mitochondria

Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation

Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells

Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only